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Abstract
Background: A number of transgenic mice carrying different deletions in the Locus Control
Region (LCR) of the mouse tyrosinase (Tyr) gene have been developed and analysed in our
laboratory. We require melanocytes from these mice, to further study, at the cellular level, the
effect of these deletions on the expression of the Tyr transgene, without potential interference with
or from the endogenous Tyr alleles. It has been previously reported that it is possible to obtain and
immortalise melanocyte cell cultures from postnatal mouse skin.
Results: Here, we describe the efforts towards obtaining melanocyte cultures from our Tyr
transgenic mice. We have bred our Tyr transgenic mice into Tyr c-32DSD mutant background, lacking
the endogenous Tyr locus. In these conditions, we failed to obtain immortalised melanocytes. We
decided to include the inactivation of the Ink4a-Arf locus to promote melanocyte immortalisation.
For this purpose, we report the segregation of the Ink4a-Arf null allele from the brown (Tyrp1b)
mutation in mice. Finally, we found that Ink4a-Arf +/- and Ink4a-Arf -/- melanocytes had
undistinguishable tyrosine hydroxylase activities, although the latter showed reduced cellular
pigmentation content.
Conclusion: The simultaneous presence of precise genomic deletions that include the tyrosinase
locus, such as the Tyr c-32DSD allele, the Tyr transgene itself and the inactivated Ink4a-Arf locus in
Tyrp1B genetic background appear as the crucial combination to perform forthcoming experiments.
We cannot exclude that Ink4a-Arf mutations could affect the melanin biosynthetic pathway.
Therefore, subsequent experiments with melanocytes will have to be performed in a normalized
genetic background regarding the Ink4a-Arf locus.
Background
Eukaryotic genes are organised on chromosomes in units
known as expression domains, that are believed to
include all regulatory elements required for correct gene
expression [1]. We use the mouse tyrosinase locus (Tyr) as
an experimental model to study mammalian expression
domains [2,3]. The mouse Tyr gene is located in chromo-
some 7 [4], encodes the rate-limiting enzyme in melanin
biosynthesis and is tightly regulated during development,
being exclusively expressed in neural crest-derived
melanocytes and optic cup-derived retinal pigment epi-
thelium (RPE) cells [5,6].
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ulatory elements has been testing a series of DNA con-
structs containing different amounts of regulatory
sequences in transgenic animals. Minigene Tyr constructs
were able to rescue the albino phenotype of recipient ani-
mals, but displayed variability in pigmentation [7,8]. In
contrast, the generation of transgenic mice with a 250 kb
yeast artificial chromosome (YAC) covering the entire
mouse Tyr locus completely rescued the albino pheno-
type, resulting in mice that were indistinguishable from
agouti wild-type pigmented mice [9,10]. These results
pointed to the existence of important regulatory elements,
absent in previous standard constructs, such as the locus
control region (LCR), identified 15 kb upstream of the
mouse Tyr promoter [11,12]. The LCR is necessary to
establish the proper expression pattern of the mouse tyro-
sinase gene. The absence of the LCR resulted in weaker
pigmentation, variegated expression in the melanocytes
and RPE cells and delayed retinal pigmentation in trans-
genic mice [13]. Moreover, two binding boxes for nuclear
factors within the LCR core, known as boxes A and B, were
identified by in vitro analysis [14] and, recently, have
been incorporated into a new boundary activity associ-
ated within the LCR region [15]. We have generated trans-
genic mice with new YAC Tyr transgenes carrying a range
of specific mutations within the LCR region [10].
To address a more detailed study, both at the functional
and structural level (using biochemical and cellular
approaches), of the role of LCR-variants in these different
transgenes, a number of problems had to be solved,
including: (1), the dispersed nature of melanocytes which
prevented us from direct analysis of relevant tissues, such
as skin, where many other unrelated cell types are found;
(2), the tyrosinase albino allele (Tyr c), present in all recip-
ient mouse strains used for the generation of transgenic
mice, carrying a reported point-mutation within the cod-
ing region that results in a non-functional protein, with-
out the transcriptional status of the locus being affected
[16-18], and, [3], although it has been demonstrated that
it is possible to obtain mouse melanocyte immortal cell
lines from postnatal skins [19-22], often it becomes diffi-
cult to overcome the senescence period that all primary
cell cultures undergo.
In this study we describe our efforts and the strategy to
obtain melanocyte cell cultures from YAC Tyr transgenic
mice in a genetic background lacking the endogenous
mouse tyrosinase gene, and the effect of the inactivation
of the Ink4a-Arf locus [23] on proliferation, senescence
and tyrosinase activity of established melanocyte cell
lines.
Results and discussion
Transfer of YAC Tyr transgenes from albino outbred NMRI 
mice (Tyr c / Tyr c) to a Tyr c-32DSD / Tyr c-32DSD 
background
Previous Tyr transgenic mice have been generated in
albino outbred NMRI mice [9,10,12]. All observed pig-
mentation is due to the expression of the Tyr transgene
but the presence of mutant albino Tyr protein and mRNA
from the host Tyr c allele [16-18] could interfere in subse-
quent cellular, biochemical and genomic analyses. The
albino 32DSD mutant mouse (Tyr c-32DSD) carries a dele-
tion of the entire Tyr locus, encompassing ~200 kb of
mouse chromosome 7 [24]. Therefore, a breeding pro-
gram was established between Tyr transgenic and albino
32DSD mice in order to obtain Tyr transgenes in animals
lacking the endogenous Tyr alleles. Genotype analysis of
the resulting mice was carried out by Southern blot. An
EcoR I restriction fragment length polymorphism (RFLP)
in exon 2 detected by the RFLP probe allows the
identification of the transgenic Tyr allele (17 kb), derived
from the mouse C3H strain, and the endogenous counter-
part albino Tyr c NMRI allele (12 kb) (9) (Fig. 1).
Transfer of YAC Tyr transgenes from a Tyr c / Tyr c back-ground to a Tyr c-32DSD / Tyr c-32DSD backgroundFig r  1
Transfer of YAC Tyr transgenes from a Tyr c / Tyr c 
background to a Tyr c-32DSD / Tyr c-32DSD background. 
Southern blot analysis of representative mice obtained during 
the breeding program, using the RFLP [9] and p19Arf E1 
probes. Lanes: (M) 1 kb-ladder (Invitrogen), (1) YAC Tyr 
YRT2/∅ [9]; Tyr c-32DSD / Tyr c, (2) YRT2/∅ ; Tyr c-32DSD / Tyr c-
32DSD, (3) ∅/∅ ; Tyr c-32DSD / Tyr c, and (4) ∅/∅ ; Tyr c-32DSD / 
Tyr c-32DSD. Note: ∅ indicates the absence of the transgene. 
Tg: YAC Tyr transgene derived signal. Tyr c: endogenous 
albino tyrosinase locus. p19: The p19Arf E1 probe (kindly pro-
vided by M. Malumbres), detecting exon 1 of the single-copy 
p19arf gene, was employed as an internal control for DNA 
loading and comparisons.Page 2 of 9
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Tyr c-32DSD
To gain further insight on a series of YAC Tyr transgenic
mice carrying a range of deletions around the LCR
[10,12], we decided to prepare cell lines that could be rep-
resentative of these animals. Chromatin analyses cannot
be done in tissue samples obtained directly from trans-
genic animals, due to the low number of cells expressing
the Tyr gene (RPE cells and melanocytes) and the com-
plexity of the tissues or organs containing these cells (eye
and skin, respectively). In addition, the presence of the
mutated, but transcriptionally active [16-18], albino Tyr
locus in all transgenic mice generated to date could inter-
fere with the interpretation and the acquisition of experi-
mental data. To avoid this problem we mobilised the YAC
Tyr transgenes to a genetic background lacking the endog-
enous mouse gene, as shown in Fig. 1, and then we tried
to establish melanocyte cultures from these mice.
Mouse melanocyte immortal cell lines can be derived
from postnatal skins [19-22]. Mouse crosses were estab-
lished with parental lines to obtain pigmented pups with
the desired genotype (YAC Tyr / ∅ ; Tyr c-32DSD / Tyr c-
32DSD). Genotype analysis was not necessary to distinguish
between transgenic and non transgenic pups, because
melanin, clearly visible in the eye and in the skin at this
stage, could only derive from the YAC Tyr transgene
expression. Melanocyte primary cultures from dorsal skin
of heterozygous YAC Tyr transgenes in homozygous Tyr c-
32DSD background were prepared as described [19]. Indi-
vidual melanocytes and small melanocytes colonies
appeared at culture day 10. The number of cells increased
slowly until day 25–35, when melanocytes showed signs
of senescence. Most cells died by day 85–90 and no
immortal cell lines could be established (Fig. 2A–C). Sim-
ilar results were obtained from all YAC Tyr derivative
transgenes bred to homozygous Tyr c-32DSD mice.
Mouse melanocyte primary cultures and their correspond-
ing immortalised cell lines have been established from a
number of mutant mice [25-29], although this type of cell
lines can be sometimes difficult to achieve, as it may be
inferred from these listed publications, in which reported
cell lines have been generated by the same laboratory. A
number of parameters can influence the success in obtain-
ing immortalised melanocytes from mice. First, skins
from mouse pups are used as starting material, carrying
bacteria and other microorganisms that can contaminate
the cultures. Second, and most important, melanocytes, as
any somatic cell line in culture, undergo a senescence step
previous to their immortalisation. Due to the low number
or surviving cells after this senescence step, cells need to
be cultured continuously during a minimum of 3–6
months to obtain an immortal cell line [19,20]. In most
of the cultures we did not observe melanocytes after the
senescence step (Fig. 2A–C). These results were obtained
with all different primary cultures, regardless of their gen-
otype, indicating a problem at the immortalisation step.
Segregation of the Ink4a-Arf locus from the Tyrp1 b locus
It has been reported that melanocyte immortal cell lines
(i.e. melan-a and melan-c) lack the p16 protein, most likely
due to the lost of the Ink4a-Arf locus during the culture
process [30]. Melanocytes from Ink4a-Arf (-/-) null mice
proliferate exponentially without showing any signs of
senescence, thus it has been proposed that the generation
of melanocyte immortal cell lines in an Ink4a-Arf null
background would be much easier [30]. Comparable
results had been obtained before with fibroblast cultures
from Ink4a-Arf homozygous mutant mice [31]. The
absence of p16 leads to the inhibition in the inactivation
of CDK4 and CDK6. These kinases inactivate the retino-
blastoma pathway, promoting the proliferation of the
cells [32,33]. Therefore, we decided to mobilise the Ink4a-
Arf null allele into our YAC Tyr transgenic mice.
First, we had to remove the brown mutation co-segregating
with the Ink4a-Arf null allele. The murine brown locus cor-
responds to the gene encoding the Tyrosinase-related pro-
tein 1 (Tyrp1), an enzyme which is also implicated in the
melanin biosynthetic pathway [34]. It was originally
noted that the coat colour of Ink4a-Arf null mice was paler
than their wild-type littermates [23]. Indeed, biochemical
evidence was presented that was highly suggestive of
defective Tyrp1 activity in Ink4a-Arf null melanocytes
[35]. Homozygous Tyrp1 b mutant mice display less tyro-
sinase activity than wild type, because mutated forms of
the Tyrp1 protein affect tyrosinase processing [36]. Nota-
bly, the Tyrp1 locus, is close to the Ink4a-Arf locus, in
mouse chromosome 4, at a distance of 8.7 Mb (mouse
ENSMBL, build 32). Most inbred laboratory strains with
defective Tyrp1 activity carry the recessive brown allele,
Tyrp1 b that contains a single amino acid change at a criti-
cal residue in the Tyrp1 protein [37]. To test directly
whether the Ink4a-Arf null allele was linked to the Tyrp1 b
allele, two single nucleotide polymorphisms (SNPs) that
characterize the Tyrp1 b allele and that can be diagnosed by
subsequent restriction enzyme digestion [37] were used.
In particular, a Tyrp1 b-linked SNP at exon 4 eliminates a
Taq I restriction site and, similarly, another Tyrp1 b –
linked SNP at exon 5 eliminates an Hga I restriction site.
Using these two markers, we directly proved that the orig-
inal Ink4a-Arf null mice were indeed homozygous for the
Tyrp1 b allele, thus explaining their paler coat colour (Fig.
3). The Tyrp1 b recessive allele linked to the mutated Ink4a-
Arf allele was probably derived from the ES cell line
originally used for targeting the Ink4a-Arf locus, namely
WW6 ES cells, which had a complex genetic background
[38].Page 3 of 9
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The absence of at least one Ink4a-Arf allele overcomes the senescence of primary melanocytes in culture. 
Melanocytes from heterozygous YAC Tyr transgenic in homozygous Tyr c-32DSD background became large, flat, vacuolated and 
highly pigmented (A, B). No surviving melanocytes were detected in the culture dishes after the senescence step (C). Melano-
cytes from Ink4a-Arf +/- (G, H, I) and Ink4a-Arf -/- (J, K, L) mutant mice in a Tyrp1B background are black, small, bipolar, pale and 
without significant sings of senescence, as compared to wild type Ink4a-Arf +/+ melanocytes (D, E, F). A: culture at day 10; B: cul-
ture at day 18; C: culture at day 48; D, G, J: cultures at day 43; E, H, K: cultures at day 57; and, F, I, L: cultures at day 82. Scale 
ebars in C, D, G, J = 200 µm and in A, B, E, F, H, I, K, L = 150 µm.Page 4 of 9
(page number not for citation purposes)
BMC Cell Biology 2005, 6:18 http://www.biomedcentral.com/1471-2121/6/18Ink4a/Arf-null strain in a pure C57BL/6J genetic back-
ground and unlinked from the mutant Tyrp1 b allele were
obtained to avoid the confounding presence of the Tyrp1
b allele. Ink4a-Arf +/- mice were backcrossed seven times
with wild-type C57BL/6J mice, eventually yielding Ink4a-
Arf +/- ; Tyrp1 B/ Tyrp1 b mice. These mice were intercrossed
to produce a number of Ink4a-Arf -/- mice that were in their
majority Ink4a-Arf -/- ; Tyrp1 b/ Tyrp1 b and, accordingly,
had a brown coat. Exceptionally, one mouse (from a total
population of 27 Ink4a-Arf -/- mice) was identified as an
Ink4a-Arf -/- but had a black coat. This mouse turned out to
represent a recombinant with an Ink4a-Arf -/- ; Tyrp1 B/
Tyrp1 b genotype. From this animal, and after the appro-
priate crosses, a strain of mice in C57BL/6J background
that were Ink4a-Arf -/- ; Tyrp1 B / Tyrp1 B was obtained (Fig.
3), and used for subsequent experiments.
Melanocyte primary cultures from Tyrp1 B/ Tyrp1 B 
Ink4a-Arf mutant mice
To evaluate the effect of the inactivation of the Ink4a-Arf
locus in Tyrp1 B / Tyrp1 B genetic background on the
immortalisation of mouse melanocytes, melanocyte pri-
mary cultures from dorsal skin of Ink4a-Arf +/+, Ink4a-Arf
+/-, Ink4a-Arf -/- pups in a Tyrp1 Bbackground were prepared
(Fig. 2D–L), using the same described procedures [19].
Individual melanocytes and colonies appeared at day 10.
The number of cells increased slowly in Ink4a-Arf +/+ (Fig.
4A) and, around day 35, melanocytes increased their size
and lost their bipolar shape. Few or none Ink4a-Arf +/+
melanocytes survived the senescence step, and most of
these melanocytes died by day 85–90 (Fig. 2D–F). In con-
trast, Ink4a-Arf +/- and Ink4a-Arf -/- kept their bipolar shape
and small size, with a limited number of cells showing
any sign of senescence (Fig. 2G–L). Proliferation of Ink4a-
Arf -/- melanocytes was higher than in Ink4a-Arf +/- melano-
cytes, and both were much higher than in Ink4a-ARF +/+
melanocytes (Fig. 4A). By day 45 of culture, Ink4a-Arf -/-
melanocytes entered the exponential phase of growth. In
contrast, Ink4a-Arf +/- melanocytes did not show evidences
of exponential growth until day 65 (Fig. 4A). This delay
could be explained by LOH (loss of heterozygosity), spon-
taneously occurring in Ink4a-Arf +/- melanocytes and
affecting the remaining wild-type allele of the Ink4a-Arf
locus, a common event that is known to take place both
in vitro [39] and in vivo [40]. Similar results have been
reported [30] using independent mouse colonies.
Tyrosinase activity and melanin content in the melanocyte 
cultures from Ink4a-Arf mutant mice
A valid approach to analyse the role of the different regu-
latory regions of the mouse Tyr gene in the transcription
of the locus and, eventually, in the amount of mature pro-
tein being made, is the measurement of the enzymatic
activity of the derived Tyr protein. We measured the levels
of Tyr enzymatic activity and melanin content using
reported procedures [41] in melanocyte cultures, to study
Generation of an inbred Ink4a/Arf -/-; Tyrp1 B / Tyrp1 Bmouse strainFigure 3
Generation of an inbred Ink4a/Arf -/-; Tyrp1 B / Tyrp1 Bmouse strain. Illustrative examples of the genotyping of the Tyrp1 
locus by PCR and digestion with Taq I (A) or Hga I (B). Gel lanes correspond to: (1) Ink4a/Arf -/- ; Tyrp1 b / Tyrp1 b, (2) Ink4a/Arf 
+/- ; Tyrp1 B / Tyrp1 b, (3) Ink4a/Arf -/- ;Tyrp1 B / Tyrp1 b and (4) Ink4a/Arf -/- ; Tyrp1 B / Tyrp1 B.Page 5 of 9
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The effect of Ink4a-Arf locus on cell growth and Tyr enzymatic activity. (A) Cell growth of Ink4a-Arf -/- (open circles), 
Ink4a-Arf +/- (closed circles) and Ink4a-Arf +/+ (crosses) melanocytes. Each point represents one subculture step and represents 
the mean count of cells from three replicates. (B) Tyrosine hydroxylase activity in albino melan-c (white bars), [Ink4a-Arf +/-; 
Tyrp1 B / Tyrp1 B ] (dark-grey bars), [Ink4a-Arf -/- ; Tyrp1 B / Tyrp1 B ] (light-grey bars) and melan-a (black bars) cells. (C) Melanin 
content in the same cellular types, as in (B). Bars represent the mean value (+/- SD) from three replicates. Tyrosinase activity 
and melanin content were measured in melanocyte primary cultures at passage 8 (~day 70 of culture). Statistically significant 
differences (t-Student test) are indicated as follows: * p < 0,1; ** p < 0,01; *** p < 0,001.Page 6 of 9
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in the expression of the Tyr gene. Tyrosine hydroxylase
activity values from Ink4a-Arf -/- and Ink4a-Arf +/- cell
extracts were undistinguishable and significantly lower to
values obtained in melan-a cells (Fig. 4B). However, the
quantity of melanin in the proliferative Ink4a-Arf -/-
melanocytes cell cultures was significantly lower than in
Ink4a-Arf +/- or melan-a cells (Fig. 4C).
Differences in melanin content could be explained by dif-
ferent individual cell culture response to TPA or/and CT
that are present in cell culture medium. However, the
observed differences in cellular pigmentation were main-
tained after removing CT from cell culture medium. In
addition, TPA is always required as an additive to main-
tain cellular proliferation. Increasing the amount of TPA
does not result in a parallel increase in pigmentation,
opposite to what is observed with CT.
Differences in melanin content could also be explained by
the control of the retinoblastoma (RB) protein by p16,
and the observation that RB protein interacts with the
transcription factor microphthalmia (Mift) [42], that con-
trols the expression of the Tyr gene. Differences between
Ink4a-Arf mutant cells and melan-a could be due to the
presence of a number of additional alterations in this lat-
ter immortal cell line, such as the loss of expression of
p16Ink4a [30]. The recent generation of mice with
increased gene dosage of Ink4a-Arf will be instrumental to
further investigate the influence of this locus on Tyr activ-
ity [43].
Conclusion
With all these results we can conclude that the simultane-
ous presence of: [1] at least one mutant allele of the Ink4a-
Arf locus; [2], the Tyr c-32DSD mutant albino allele in
homozygosis and; [3], the presence of the relevant Tyr
transgene in heterozygosis, are required for the establish-
ment and the study of immortal mouse melanocyte cul-
tures from transgenic mice carrying Tyr constructs. Finally,
we cannot exclude that Ink4a-Arf mutations could affect
the melanin biosynthetic pathway. Therefore, experi-
ments with mouse melanocytes will have to be performed
in a normalized genetic background regarding the Ink4a-
Arf locus.
Methods
Animals
Four types of mice were used in this study: YRT2 YAC tyro-
sinase heterozygous transgenic mice in an albino outbred
NMRI background (YRT2/∅ ; Tyr c / Tyr c) (line #1999) [9],
32DSD radiation induced albino mutant mice (Tyr c-
32DSD/ Tyr c-32DSD) [24], homozygous Ink4a-Arf mutant
mice (Tyr + / Tyr + ; Tyrp1 b / Tyrp1 b ; Ink4a-Arf -/-) in C57BL/
6J genetic background [23] and wild-type pigmented
C57BL/6J mice. All experiments complied with local and
European legislation concerning vivisection and the
experimentation and use of animals for research
purposes.
Southern blot analysis
The discrimination of the endogenous tyrosinase gene
from the YAC-tyrosinase transgenes was performed as pre-
viously described, using the RFLP probe, containing exon
2 of the mouse tyrosinase gene [9,12]. To obtain an endog-
enous internal control, membranes were co-hybridised
with a single-copy mouse gene, the p19Arf E1 probe, a EcoR
I DNA fragment, 230 bp in length, containing exon 1 of
the p19Arf gene (pRSp19arfE1 plasmid, generous gift from
M. Malumbres). In brief, genomic DNA was isolated from
mice tail tips and prepared for southern blot as described
[12]. 15–20 µg of genomic DNA were digested with EcoR
I (Roche, Basel, Switzerland), fractionated by horizontal
gel electrophoresis in 0,8% agarose and transferred to a
Hybond-N nylon membrane (Amersham, Buckingham-
shire, UK) by capillary blotting. RFLP and p19Arf E1 DNA
probes were labelled with [α32P] dCTP using the High
Prime labelling kit (Roche). Membranes were hybridised
in Southern hybridisation solution (0.25 M Na2HPO4 pH
= 7.2, 7% SDS, 1% BSA) overnight at 65°C, washed at
65°C in 20 mM Na2HPO4 pH = 7.2, 1% SDS, 1 mM EDTA
pH = 8 and resulting blots exposed for 1–3 days and
scanned with a PhosphorImager (Molecular Dynamics,
Sunnyvale, CA, USA). Quantification of the hybridisation
signals was performed using the ImageQuant v1.2 soft-
ware (Molecular Dynamics).
Genotyping of the Ink4a-Arf and Tyrp1 loci
The Ink4a-Arf and Tyrp1 loci were genotyped by PCR as
follows. The Ink4a-Arf wild-type allele was specifically
detected using primers that amplify Ink4a-Arf exon 2:
mp16F, 5'-ATGATGATGGGCAACGTTC-3' and mp16R,
5'-CAAATATCGCACGATGTC-3'. The Ink4a-Arf null allele,
which has a neo-cassette substituting exons 2 and 3 [23],
was genotyped using primers that hybridise, respectively,
with the neo-cassette (oligo Neo) and with Ink4a-Arf flank-
ing genomic sequences (oligo R1): Neo, 5'-CTATCAGGA-
CATAGCGTTGG-3' and R1, 5'-
AGTGAGAGTTTGGGGACA GAG-3'. To genotype the
Tyrp1 locus, two different PCR reactions were performed
to amplify, respectively, exons 4 and 5 of the Tyrp1 gene.
Amplification of exon 4 was performed using primers:
Tyrp1-4F, 5'-CTGCGATGTCTGCACTGATGACTT-3' and
Tyrp1-4R, 5'-AGGGTATCGTACTCTTCCAAGGAT-3'.
Amplification of exon 5 was performed using primers:
Tyrp1-5F, 5'-ACAGCACTGAGGGTGGACCAATC-3' and
Tyrp1-5R, 5'-AGGGTATCGTACTCTTCCAAGGAT-3'. After
amplification, the product corresponding to exon 4 was
digested with Taq I, and the product corresponding to
exon 5 was digested with Hga I. Digestion mixtures werePage 7 of 9
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ethidium bromide. The Tyrp1 bmutant allele does not con-
tain neither of the previous restriction sites, Taq I and Hga
I, whereas both enzymes digest the Tyrp1 B wild-type
allele. PCR reactions had 3 mM MgCl2, 1% DMSO, 2.5
mM dNTPs (Epicentre, Madison, WI, USA), 20 pmol of
each primer, and 0.25 µl of Taq-Gold (Applied Biosys-
tems, Foster City, CA, USA). In addition, each reaction
had approximately 100 ng of genomic DNA extracted
from the tail tips. Annealing temperature was 60°C and
PCR reactions were carried on for 30 amplification cycles.
Melanocyte cultures
Melanocyte cultures were prepared, essentially, as previ-
ously described [19]. Briefly, dorsal skin biopsies were
obtained from pups of all investigated genotypes between
+19.5 and +22.5 d.p.c. stages (postnatal P2–P3). Dorsal
skin was split in 5 µg/ml trypsin (Sigma, St. Louis, MO,
USA) in PBS and the epidermal layer then minced with a
pair of surgical blades in 250 µg/ml trypsin and 200 µg/
ml EDTA in PBS. Cells were cultured on a feeder layer of
mitomycin-treated murine XB2 keratinocytes [44]. The
cells were grown in RPMI-1640 medium containing 2 mM
glutamine, 10% fetal calf serum, 100000 U/l penicillin,
100 mg/l streptomycin sulphate (all from Invitrogen,
Carlsbad, CA, USA), 200 nM tetradecanoyl phorbol ace-
tate (TPA) (Sigma) and 200 pM cholera toxin (CT)
(Sigma), at 37°C, 95% humidity and 10% CO2 pressure.
Explant cultures from different donor mice were kept sep-
arate. Passages were made when cultures became subcon-
fluent, and melanocytes were counted at each passage.
Feeder cells were added when necessary. Control melan-a
and melan-c cells, derived from inbred C57BL/6J and out-
bred albino LAC-MF1 mice, respectively, were cultured as
previously described [19,20].
Quantification of melanin and tyrosinase enzymatic 
activities
Melanin contents in whole cell extracts were measured by
spectrophotometer essentially as described [45]. In brief,
6 × 106 cells from ~day 70 of culture were collected and
homogenised in 300 µl of PBS, 100 µl of homogenate
incubated for 14–16 hours at room temperature with 900
µl of 2 M NaOH, 20% DMSO and absorbance measured
at 470 nm.
Tyrosinase enzymatic activities were recorded following
described assays [41,46,47]. In brief, for tyrosine hydrox-
ylase activity, 6 × 106 cells from ~day 70 of culture were
collected and cell extracts were prepared in 10 mM
Sodium Phosphate buffer pH = 6.8 to which Tween-20
(Igepal) was added (1% final concentration) prior the
assay. Reaction volume included 10 µl of L-DOPA 250
mM, 10 µl of L-[3,5-3H]-Tyrosine mix (450 µl of L-Tyro-
sine 262 µM in 10 mM Sodium Phosphate buffer pH = 6.8
and 50 µl L-[3,5-3H]-Tyrosine [1 mCi/ml, 46 Ci/mmol,
Amersham]), 20 µl of Sodium Phosphate buffer pH = 6.8
and 10 µl of cell extracts, was incubated for 1 hour at
37°C, and stopped by adding 450 µl trichloracetic acid
(TCA) 1% (Merck, Darmstadt, Germany). A small amount
of absorbing substrate (active carbon [Merck] and Celite
545 [Fluka, St. Gallen, Switzerland], 1:1) was added,
mixed for 30 min at room temperature and centrifuged.
Radioactivity from clear supernatants (100 µl) was
measured in a β-scintillation counter (Beckmann, Fuller-
ton, CA, USA).
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